FT
Flare Therapeutics utilizes a novel approach to target switch sites on transcription factors, enabling the development of small molecule medicines that can precisely modulate gene expression. The company focuses on creating therapies for precision oncology by addressing the challenges of drugging previously inaccessible transcription factors.
Boston, United StatesFounded 2021
Updated 4 months ago
Funding
$205M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Flare Therapeutics utilizes a novel approach to target switch sites on transcription factors, enabling the development of small molecule medicines that can precisely modulate gene expression. The company focuses on creating therapies for precision oncology by addressing the challenges of drugging previously inaccessible transcription factors.